학술논문
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
Document Type
Journal Article
Author
White, Michael T; Verity, Robert; Griffin, Jamie T; Asante, Kwaku Poku; Owusu-Agyei, Seth; Greenwood, Brian; Drakeley, Chris; Gesase, Samwel; Lusingu, John; Ansong, Daniel; Adjei, Samuel; Agbenyega, Tsiri; Ogutu, Bernhards; Otieno, Lucas; Otieno, Walter; Agnandji, Selidji T; Lell, Bertrand; Kremsner, Peter; Hoffman, Irving; Martinson, Francis
Source
Subject
*MALARIA
*VACCINE effectiveness
*RANDOMIZED controlled trials
*CIRCUMSPOROZOITE protein
*TARGETED drug delivery
*PLASMODIUM falciparum
*PREVENTION
*VACCINATION
*MALARIA prevention
*CLINICAL medicine
*CLINICAL trials
*COMPARATIVE studies
*IMMUNIZATION
*IMMUNOGENETICS
*IMMUNOGLOBULINS
*RESEARCH methodology
*EVALUATION of medical care
*MEDICAL cooperation
*PROTEINS
*PROTOZOA
*RESEARCH
*RESEARCH funding
*VACCINES
*EVALUATION research
*TREATMENT effectiveness
*DISEASE incidence
*CHEMICAL inhibitors
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1473-3099
Abstract